Use of topical clascoterone for the treatment of hidradenitis suppurativa

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease of the hair follicle that causes debilitating recurrent and painful nodules, abscesses, fistulae, sinus tracts, foul smelling drainage, and scars, primarily in the axillary, inguinal, inframammary, and perianal areas, leading to patient embarrassment and poor quality of life.1 Despite estimates of prevalence of up to approximately 4%,1,2 there is currently only 1 Food and Drug Administration–approved treatment, the tumor necrosis factor-α inhibitor adalimumab.

Topics & Concepts